5-Trifluoromethyl-1-(3,4,5-trimethoxy-benzyl)-1,2,3,4-tetrahydro-isoquinoline-6,7-diol

ID: ALA143645

PubChem CID: 15133335

Max Phase: Preclinical

Molecular Formula: C20H22F3NO5

Molecular Weight: 413.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(CC2NCCc3c2cc(O)c(O)c3C(F)(F)F)cc(OC)c1OC

Standard InChI:  InChI=1S/C20H22F3NO5/c1-27-15-7-10(8-16(28-2)19(15)29-3)6-13-12-9-14(25)18(26)17(20(21,22)23)11(12)4-5-24-13/h7-9,13,24-26H,4-6H2,1-3H3

Standard InChI Key:  BHLICJAYUSKMQT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    3.4500   -1.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1667   -1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1625   -2.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417   -0.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7375   -1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4500   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -5.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7375   -2.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8792   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0125   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2917   -5.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5875   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5917   -2.5417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750   -3.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3000   -3.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5792   -5.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417    0.2833    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.1042    0.0750    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.7750    0.0708    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250   -1.3000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7250   -5.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0250   -2.9500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8792   -1.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7292   -3.7792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2917   -6.2500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5917   -1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4417   -5.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7250   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0042   -6.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  1  1  0
  5  1  1  0
  6  8  1  0
  7 11  2  0
  8  5  2  0
  9  3  1  0
 10 15  2  0
 11 16  1  0
 12 14  1  0
 13 26  1  0
 14  9  1  0
 15 12  1  0
 16 12  2  0
 17  4  1  0
 18  4  1  0
 19  4  1  0
 20  5  1  0
 21  7  1  0
 22  8  1  0
 23  2  1  0
 24 10  1  0
 25 11  1  0
 26 23  1  0
 27 21  1  0
 28 24  1  0
 29 25  1  0
  3  6  2  0
 13  9  1  0
 10  7  1  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Beta-1 adrenergic receptor (895 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tbxa2r Thromboxane A2 receptor (199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 413.39Molecular Weight (Monoisotopic): 413.1450AlogP: 3.57#Rotatable Bonds: 5
Polar Surface Area: 80.18Molecular Species: BASEHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.04CX Basic pKa: 8.94CX LogP: 2.72CX LogD: 2.33
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.65Np Likeness Score: 0.82

References

1. Markovich KM, Tantishaiyakul V, Hamada A, Miller DD, Romstedt KJ, Shams G, Shin Y, Fraundorfer PF, Doyle K, Feller DR..  (1992)  Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.,  35  (3): [PMID:1346651] [10.1021/jm00081a007]

Source